Journal of Epidemiology and Global Health

Next Article In Issue>
Volume 9, Issue 4, December 2019, Pages 217 - 222

Current Cancer Epidemiology

Authors
Camilla Mattiuzzi1, Giuseppe Lippi2, *
1Service of Clinical Governance, Provincial Agency for Social and Sanitary Services, Trento, Italy
2Section of Clinical Biochemistry, University of Verona, Verona, Italy
*Corresponding author. Email: giuseppe.lippi@univr.it
Corresponding Author
Giuseppe Lippi
Received 9 July 2019, Accepted 5 October 2019, Available Online 17 October 2019.
DOI
10.2991/jegh.k.191008.001How to use a DOI?
Keywords
Cancer; epidemiology; statistics; frequency; mortality
Abstract

In this brief report, we offer a concise overview on current cancer epidemiology garnered from the official databases of World Health Organization and American Cancer Society and provide recent information on frequency, mortality, and survival expectancy of the 15 leading types of cancers worldwide. Overall, cancer poses the highest clinical, social, and economic burden in terms of cause-specific Disability-Adjusted Life Years (DALYs) among all human diseases. The overall 0–74 years risk of developing cancer is 20.2% (22.4% in men and 18.2% in women, respectively). A total number of 18 million new cases have been diagnosed in 2018, the most frequent of which are lung (2.09 million cases), breast (2.09 million cases), and prostate (1.28 million cases) cancers. Beside sex-specific malignancies, the ratio of frequency between men and women is >1 for all cancers, except thyroid (i.e., 0.30). As concerns mortality, cancer is the second worldwide cause of death (8.97 million deaths) after ischemic heart disease, but will likely become the first in 2060 (~18.63 million deaths). Lung, liver, and stomach are the three most deadly cancers in the general population, while lung and breast cancers are the leading causes of cancer related-mortality in men and women, respectively. Prostate and thyroid cancers have the best prognosis, with 5-year survival ~100%, while esophagus, liver, and especially pancreas cancers have the worst prognosis, typically <20% at 5 years. We hope that this report will provide fertile ground for addressing health-care interventions aimed at preventing, diagnosing, and managing cancer around the world.

Copyright
© 2019 Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

Next Article In Issue>
Journal
Journal of Epidemiology and Global Health
Volume-Issue
9 - 4
Pages
217 - 222
Publication Date
2019/10/17
ISSN (Online)
2210-6014
ISSN (Print)
2210-6006
DOI
10.2991/jegh.k.191008.001How to use a DOI?
Copyright
© 2019 Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

risenwbib
TY  - JOUR
AU  - Camilla Mattiuzzi
AU  - Giuseppe Lippi
PY  - 2019
DA  - 2019/10/17
TI  - Current Cancer Epidemiology
JO  - Journal of Epidemiology and Global Health
SP  - 217
EP  - 222
VL  - 9
IS  - 4
SN  - 2210-6014
UR  - https://doi.org/10.2991/jegh.k.191008.001
DO  - 10.2991/jegh.k.191008.001
ID  - Mattiuzzi2019
ER  -